SF-86-HL84

N/A

Report date: 2025/01/26 15:10:16
NME

Base Information

Drug NameSF-86-HL84
Drug Alias NameALK2 inhibitor (Novartis Institutes for BioMedical Research)SF-86-HL84
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionActivin receptor type-1 inhibitors
TargetsActivin receptor type-1
Therapy Area/IndicationsMyositis Ossificans
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Institutes For Biomedical Research Inc
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Institutes For Biomedical Research Inc
Inactive CompaniesN/A
Active IndicationsMyositis Ossificans
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A